Literature DB >> 9765508

Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance.

S Chakrabarti1, M Rivera, S Z Yan, W J Tang, A R Gintzler.   

Abstract

In the current study, we investigated the neurochemical basis for the previously reported predominance of stimulatory mu-opioid signaling in guinea pig longitudinal muscle/myenteric plexus (LMMP) preparations after chronic in vivo morphine exposure. As expected, recombinant Gsalpha (rGsalpha) dose-dependently stimulated adenylyl cyclase (AC) activity in LMMP membranes obtained from opioid naive as well as tolerant LMMP tissue. However, the magnitude of the increase was significantly greater in the latter than in the former. The Gbetagamma blocking peptide QEHA (50 microM) essentially abolished stimulation by rGsalpha in LMMP membranes obtained from both opioid naive and tolerant animals. Interestingly, after partial blockade by lower QEHA concentrations, the incremental AC stimulation by rGsalpha in tolerant LMMP membranes was no longer observed, indicating augmented Gbetagamma stimulatory responsiveness. Concomitant changes in the content of AC isoform protein are consistent with these biochemical observations. After chronic systemic morphine, AC protein is augmented significantly (56%). This increment is most likely to be composed of AC isoforms that are stimulated by Gbetagamma. This is the first demonstration in a complex mammalian tissue that persistent activation of opioid receptors results in augmented Gbetagamma/Gsalpha AC stimulatory interactiveness. The relevance of such changes to the manifestation of opioid tolerance is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765508

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling.

Authors:  S Chakrabarti; M Oppermann; A R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

3.  Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.

Authors:  Ester Schallmach; Debora Steiner; Zvi Vogel
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

5.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

Review 6.  G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants.

Authors:  David Chakravorty; Sarah M Assmann
Journal:  Biochem J       Date:  2018-11-09       Impact factor: 3.857

7.  Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

Authors:  M K Mundey; A Ali; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

8.  Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway.

Authors:  Hai-Yu Yang; Zhi-Yuan Wu; Mark Wood; Matthew Whiteman; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2013-07-11       Impact factor: 8.401

9.  Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.

Authors:  Tally M Largent-Milnes; Wenhong Guo; Hoau-Yan Wang; Lindsay H Burns; Todd W Vanderah
Journal:  J Pain       Date:  2008-05-12       Impact factor: 5.820

10.  Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.

Authors:  Susan L Ingram; Tara A Macey; Erin N Fossum; Michael M Morgan
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.